PEPperPRINT GmbH contributed to a study in Advanced Science by using its peptide microarray technology to map the binding sites of two anti-Doppel antibodies, 4D6 and 5C7, and identify specific regions recognized by each antibody.
Public source
Publisher name
Public post
Tumors need a blood supply to keep growing. And they can get one by encouraging nearby blood vessels to grow new branches toward them. New blood vessel formation, or ang…
Company
PEPperPRINT GmbH
The leading provider of high-density peptide microarrays for antibody validation, epitope mapping & antigen discovery.
- Industry
- Biotechnology Research
- Location
- Heidelberg, DE
- Company size
- 11–50 employees
About PEPperPRINT GmbH
PEPperPRINT is an innovative biotech company from Heidelberg, Germany, and the leading provider of high density peptide and protein microarrays for antibody characterization or the fingerprint analysis of antibody responses from biological samples. The product and service portfolio was recently complemented by T cell epitope mapping and monitoring, making PEPperPRINT a one-stop solution provider for the fingerprint analysis of immune responses e.g. for epitope mapping, antibody biomarker discovery or the analysis of adverse immune effects. PEPperPRINT’s peptide microarrays and screening services have been used by researchers around the world with over 200 peer-reviewed publications.
See moreLatest activity
Latest activity from PEPperPRINT GmbH
4 signals
Presence & Recognition
PEPperPRINT GmbH is attending the 14th EuroMabNet Annual Meeting in Vilnius, Lithuania from September 10 to 11, 2026, to discuss antibody research and high-resolution peptide microarrays.
Presence & Recognition
PEPperPRINT GmbH participated in a webinar by Luke Marshall from Biotome Pty Ltd to walk through a stepwise workflow for converting broad PhIP-Seq discovery data into validated peptide biomarkers.
Research & Knowledge
PEPperPRINT GmbH's R&D team is developing glycopeptide microarrays to investigate antibody responses against glycosylated structures.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Proteintech Group
Proteintech Group researcher Christoph Spahn and Kilian Andress from the Nanoscale Bacteriology Lab at the Rudolf-Virchow Center (University of Würzburg) used the FlexAble Oligo-Ready Kit to label a rabbit anti-E. coli LPS primary antibody with a DNA-PAINT docking strand.
Research & Knowledge
Abbexa
Abbexa published an article exploring a new area of research challenging long-held assumptions about neurodegeneration and future possibilities.
Research & Knowledge
Aptamer Group
Aptamer Group published a case study where cell-based discovery led to beautifully specific Optimers with strong staining in ICC to identify biomarkers distinguishing between different cancer grades for staging and prognosis.
Research & Knowledge
CDI Labs
CDI Labs published three studies using CDI Labs’ HuProt™ human proteome microarray to investigate cellular targets in acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma.
Research & Knowledge
Fluidic Sciences